Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 23:15:11795441221118920.
doi: 10.1177/11795441221118920. eCollection 2022.

Radiologically Guided Versus Blinded Intra-articular Injection in Patients With Hip Osteoarthritis: A Retrospective Comparative Study

Affiliations

Radiologically Guided Versus Blinded Intra-articular Injection in Patients With Hip Osteoarthritis: A Retrospective Comparative Study

Ahmet Aksoy et al. Clin Med Insights Arthritis Musculoskelet Disord. .

Abstract

Objectives: The aim of this study was to present the clinical results of patients with Kellgren-Lawrence (KL) stage 2-4 hip osteoarthritis who were administered intra-articular corticosteroid (CS) or hyaluronic acid (HA), with or without fluoroscopy.

Methods: This retrospective comparative study was conducted in the clinics where the authors worked between 2010 and 2018. Patients with stage 2-4 hip osteoarthritis according to KL criteria were included in the study. Age, body mass index, American Society of Anesthesiologists stages, and Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores (3rd, 6th, and 12th months) were recorded. Two groups were created as patients who underwent injection with or without fluoroscopy guidance. In group 1, CS (triamnisolone) was administered, and in group 2, sodium hyaluronate 88 mg/4 mL was administered. Obtained parameters were compared.

Results: The WOMAC scores at 3 months of both the CS and HA groups were statistically significantly better than before the application, with the improvement in the CS group found to be significantly better than in the HA group (P = .047). At 6 months, the mean WOMAC scores of the CS and HA groups were better than prior to the application, and there was a statistically significant difference (P < .001). No significant difference was found in either the CS or HA group in the comparison of 12-month WOMAC scores with the baseline scores (P = .744 and P = .054).

Conclusion: In symptomatic hip OA patients, intra-articular administration of CS and HA was seen to be effective at 3 and 6 months after administration. However, the effectiveness was determined to have disappeared within 1 year. Furthermore, in hip OA intra-articular drug applications, it was determined that the blinded technique without radiological guidance performed in the outpatient clinic is as effective and safe as the radiologically guided technique administered in the operating room.

Keywords: Hip osteoarthritis; corticosteroids; fluoroscopy; hyaluronic acid; intra-articular injection.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Flowchart of patients.
Figure 2.
Figure 2.
The patient was covered with a sterile drape and 1 cm proximal to the greater trochanter (GT) was marked.
Figure 3.
Figure 3.
Observation of backflow.
Figure 4.
Figure 4.
Confirmation of needle position in the joint with contrast agent injection.
Figure 5.
Figure 5.
The junction of the vertical lines from spina iliaca anterior superior and the horizontal lines from greater trochanter are marked anteriorly.
Figure 6.
Figure 6.
After the spinal needle was inserted from front to back and bone resistance was felt, the inner needle was removed, and backflow was observed by injecting 1 to 2 ml of saline (SF). All figures submitted have been created by the authors, who confirm that the images are original with no duplication and have not been previously published in whole or in part.

Similar articles

Cited by

References

    1. Hawker GA. Osteoarthritis is a serious disease. Clin Exp Rheumatol. 2019;37:3-6. - PubMed
    1. Zhang W, Doherty M, Arden N, et al..; EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2005;64:669-681. doi:10.1136/ard.2004.028886 - DOI - PMC - PubMed
    1. Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021;325:568-578. doi:10.1001/jama.2020.22171 - DOI - PMC - PubMed
    1. Abramoff B, Caldera FE. Osteoarthritis: pathology, diagnosis, and treatment options. Med Clin North Am. 2020;104:293-311. doi:10.1016/j.mcna.2019.10.007 - DOI - PubMed
    1. Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014;5:351-361. doi:10.5312/wjo.v5.i3.351 - DOI - PMC - PubMed

LinkOut - more resources